ケモインフォマティックスの世界市場分析:製品別(全血算定、HGB / HCT検査、基本代謝パネル、BUNクレアチニン検査、電解質検査、HbA1c検査、包括的代謝パネル、肝臓パネル、腎パネル、脂質パネル)、セグメント予測、-2020...市場調査レポートについてご紹介

【英文タイトル】Clinical Laboratory Tests Market Analysis By Product (Complete Blood Count, HGB/HCT Tests, Basic Metabolic Panel, BUN Creatinine Tests, Electrolyte Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel) And Segment Forecasts To 2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Chapter 1. Executive Summary
1.1. Clinical Laboratory Tests – Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Clinical Laboratory Tests Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Clinical Laboratory Tests Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis – Porter’s
2.6. Clinical Laboratory Tests Market PESTEL Analysis, 2013
Chapter 3. Clinical Laboratory Tests by Type Outlook
3.1. Complete Blood Count (CBC)
3.1.1. CBC Tests Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.1.1.1. Primary Care Clinics CBC Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.1.1.2. Central Laboratories CBC Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.2. HGB/HCT Tests
3.2.1. HGB/HCT Tests Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.2.1.1. Primary Care Clinics HGB/HCT Tests Market Estimates and Forecasts, 2012 – 20 (USD Mn)
3.2.1.2. Central Laboratories HGB/HCT Tests Market Estimates and Forecasts, 2012 – 20 (USD Mn)
3.3. Basic Metabolic Panel (BMP)
3.3.1. BMP Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.3.1.1. Primary Care Clinics BMP Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.3.1.2. Central Laboratories BMP Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.4. BUN Creatinine Tests (BUN CT)
3.4.1. BUN CT Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.4.1.1. Primary Care Clinics BUN CT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.4.1.2. Central Laboratories BUN CT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.5. Electrolyte Testing (ET)
3.5.1. ET Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.5.1.1. Primary Care Clinics ET Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.5.1.2. Central Laboratories ET Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.6. HbA1c Tests
3.6.1. HbA1c Tests Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.6.1.1. Primary Care Clinics HbA1c Tests Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.6.1.2. Central Laboratories HbA1c Tests Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.7. Comprehensive Metabolic Panel Tests (CMPT)
3.7.1. CMPT Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.7.1.1. Primary Care Clinics CMPT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.7.1.2. Central Laboratories CMPT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.8. Liver Panel Tests (LPT)
3.8.1. LPT Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.8.1.1. Primary Care Clinics LPT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.8.1.2. Central Laboratories LPT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.9. Renal Panel Tests (RPT)
3.9.1. RPT Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.9.1.1. Primary Care Clinics RPT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.9.1.2. Central Laboratories RPT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.10. Lipid Panel Tests (LPT)
3.10.1. LPT Market Estimates and Forecasts, by Laboratory Type, 2012 – 2020 (USD Mn)
3.10.1.1. Primary Care Clinics LPT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
3.10.1.2. Central Laboratories LPT Market Estimates and Forecasts, 2012 – 2020 (USD Mn)
Chapter 4. Clinical Laboratory Tests Regional Outlook
4.1. North America
4.1.1. U.S.
4.1.1.1. U.S. Complete Blood Count by Laboratory Type, 2012 – 2020 (USD Mn)
4.1.1.2. U.S. HGB/HCT Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.1.1.3. U.S. Basic Metabolic Panel by Laboratory Type, 2012 – 2020 (USD Mn)
4.1.1.4. U.S. BUN Creatinine Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.1.1.5. U.S. Electrolytes Testing by Laboratory Type, 2012 – 2020 (USD Mn)
4.1.1.6. U.S. HbA1c Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.1.1.7. U.S. Comprehensive Metabolic Panel by Laboratory Type, 2012 – 2020 (USD Mn)
4.1.1.8. U.S. Liver Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.1.1.9. U.S. Renal Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.1.1.10. U.S. Lipid Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.2. Europe
4.2.1. Germany
4.2.1.1. Germany Complete Blood Count by Laboratory Type, 2012 – 2020 (USD Mn)
4.2.1.2. Germany HGB/HCT Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.2.1.3. Germany Basic Metabolic Panel by Laboratory Type, 2012 – 2020 (USD Mn)
4.2.1.4. Germany BUN Creatinine Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.2.1.5. Germany Electrolytes Testing by Laboratory Type, 2012 – 2020 (USD Mn)
4.2.1.6. Germany HbA1c Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.2.1.7. Germany Comprehensive Metabolic Panel by Laboratory Type, 2012 – 2020 (USD Mn)
4.2.1.8. Germany Liver Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.2.1.9. Germany Renal Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.2.1.10. Germany Lipid Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.3. Asia Pacific
4.3.1. Japan
4.3.1.1. Japan Complete Blood Count by Laboratory Type, 2012 – 2020 (USD Mn)
4.3.1.2. Japan HGB/HCT Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.3.1.3. Japan Basic Metabolic Panel by Laboratory Type, 2012 – 2020 (USD Mn)
4.3.1.4. Japan BUN Creatinine Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.3.1.5. Japan Electrolytes Testing by Laboratory Type, 2012 – 2020 (USD Mn)
4.3.1.6. Japan HbA1c Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.3.1.7. Japan Comprehensive Metabolic Panel by Laboratory Type, 2012 – 2020 (USD Mn)
4.3.1.8. Japan Liver Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.3.1.9. Japan Renal Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.3.1.10. Japan Lipid Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.4. RoW
4.4.1. Brazil
4.4.1.1. Brazil Complete Blood Count by Laboratory Type, 2012 – 2020 (USD Mn)
4.4.1.2. Brazil HGB/HCT Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.4.1.3. Brazil Basic Metabolic Panel by Laboratory Type, 2012 – 2020 (USD Mn)
4.4.1.4. Brazil BUN Creatinine Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.4.1.5. Brazil Electrolytes Testing by Laboratory Type, 2012 – 2020 (USD Mn)
4.4.1.6. Brazil HbA1c Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.4.1.7. Brazil Comprehensive Metabolic Panel by Laboratory Type, 2012 – 2020 (USD Mn)
4.4.1.8. Brazil Liver Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.4.1.9. Brazil Renal Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
4.4.1.10. Brazil Lipid Panel Tests by Laboratory Type, 2012 – 2020 (USD Mn)
Chapter 5. Competitive Landscape
5.1. Siemens
5.1.1. Company Overview
5.1.2. Revenue Analysis
5.1.3. Product Benchmarking
5.1.4. Strategic Development
5.2. Charles River Laboratories
5.2.1. Company Overview
5.2.2. Revenue Analysis
5.2.3. Product Benchmarking
5.2.4. Strategic Development
5.3. Quest Diagnostics Inc.
5.3.1. Company Overview
5.3.2. Revenue Analysis
5.3.3. Product Benchmarking
5.3.4. Strategic Development
5.4. Bioscientia Healthcare
5.4.1. Company Overview
5.4.2. Revenue Analysis
5.4.3. Product Benchmarking
5.4.4. Strategic Development
5.5. Sonic Healthcare Limited
5.5.1. Company Overview
5.5.2. Revenue Analysis
5.5.3. Product Benchmarking
5.5.4. Strategic Development
5.6. Abbott Laboratories
5.6.1. Company Overview
5.6.2. Revenue Analysis
5.6.3. Product Benchmarking
5.6.4. Strategic Development
5.7. Bio-Reference Laboratories
5.7.1. Company Overview
5.7.2. Revenue Analysis
5.7.3. Product Benchmarking
5.7.4. Strategic Development
5.8. Labco S.A.
5.8.1. Company Overview
5.8.2. Revenue Analysis
5.8.3. Product Benchmarking
5.8.4. Strategic Development
5.9. Healtscope Limited
5.9.1. Company Overview
5.9.2. Revenue Analysis
5.9.3. Product Benchmarking
5.9.4. Strategic Development
5.10. Spectra Laboratories
5.10.1. Company Overview
5.10.2. Revenue Analysis
5.10.3. Product Benchmarking
5.10.4. Strategic Development
5.11. Laboratory corporation of America Holdings (Labcorp)
5.11.1. Company Overview
5.11.2. Revenue Analysis
5.11.3. Product Benchmarking
5.11.4. Strategic Development
5.12. ARUP Laboratories
5.12.1. Company Overview
5.12.2. Revenue Analysis
5.12.3. Product Benchmarking
5.12.4. Strategic Development
5.13. Genoptix Medical Laboratory
5.13.1. Company Overview
5.13.2. Revenue Analysis
5.13.3. Product Benchmarking
5.13.4. Strategic Development
5.14. Qiagen
5.14.1. Company Overview
5.14.2. Revenue Analysis
5.14.3. Product Benchmarking
5.14.4. Strategic Development
5.15. Clarient Inc.
5.15.1. Company Overview
5.15.2. Revenue Analysis
5.15.3. Product Benchmarking
5.15.4. Strategic Development
5.16. Genzyme Corporation
5.16.1. Company Overview
5.16.2. Revenue Analysis
5.16.3. Product Benchmarking
5.16.4. Strategic Development

List of Tables
1. Global Clinical Laboratory Tests Market – Industry Summary & Critical Success Factors (CSFs)
2. Clinical Laboratory Tests – Key Market Driver Analysis
3. Clinical Laboratory Tests Market – Key Market Restraint Analysis
4. Global Clinical Laboratory Tests Market, by Test Type, 2012 – 2020 (USD Million)
5. Complete Blood Count Market, by Laboratory Type, 2012 – 2020 (USD Million)
6. HGB/HCT Tests Market, by Laboratory Type, 2012 – 2020 (USD Million)
7. Basic Metabolic Panel Market, by Laboratory Type, 2012 – 2020 (USD Million)
8. BUN Creatinine Tests Market, by Laboratory Type, 2012 – 2020 (USD Million)
9. Electrolytes Testing Market, by Laboratory Type, 2012 – 2020 (USD Million)
10. HbA1c Tests Market, by Laboratory Type, 2012 – 2020 (USD Million)
11. Comprehensive Metabolic Tests Market, by Laboratory Type, 2012 – 2020 (USD Million)
12. Liver Panel Tests Market, by Laboratory Type, 2012 – 2020 (USD Million)
13. Renal Panel Tests Market, by Laboratory Type, 2012 – 2020 (USD Million)
14. Lipid Panel Tests Market, by Laboratory Type, 2012 – 2020 (USD Million)
15. Global Clinical Laboratory Tests Market, by Region, 2012 – 2020 (USD Million)
16. North America Clinical Laboratory Tests Market, by Test Type, 2012 – 2020 (USD Million)
17. U.S. Clinical Laboratory Tests Market, by Test Type, 2012 – 2020 (USD Million)
18. Europe Clinical Laboratory Tests Market, by Test Type, 2012 – 2020 (USD Million)
19. Germany Clinical Laboratory Tests Market, by Test Type, 2012 – 2020 (USD Million)
20. Asia Pacific Clinical Laboratory Tests Market, by Test Type, 2012 – 2020 (USD Million)
21. Japan Clinical Laboratory Tests Market, by Test Type, 2012 – 2020 (USD Million)
22. RoW Clinical Laboratory Tests Market, by Test Type, 2012 – 2020 (USD Million)
23. Brazil Clinical Laboratory Tests Market, by Test Type, 2012 – 2020 (USD Million)

List of Figures
1. Global Clinical Laboratory Tests Market Segmentation
2. Global Clinical Laboratory Tests Market Revenue, (USD Million), 2012 – 2020
3. Clinical Laboratory Tests Market Dynamics
4. Clinical Laboratory Tests Market – Porter’s Analysis
5. Key opportunities prioritized
6. Clinical Laboratory Tests Market – PESTEL Analysis
7. Global Clinical Laboratory Tests Market Revenue Share by Test Type, 2013 & 2020
8. Global Complete Blood Count Market, 2012 – 2020 (USD Million)
9. Global HGB/HCT Tests Market, 2012 – 2020 (USD Million)
10. Global Basic Metabolic Panel Market, 2012 – 2020 (USD Million)
11. Global BUN Creatinine Tests Market, 2012 – 2020 (USD Million)
12. Global Electrolytes Testing Market, 2012 – 2020 (USD Million)
13. Global HbA1c Tests Market, 2012 – 2020 (USD Million)
14. Global Comprehensive Metabolic Tests Market, 2012 – 2020 (USD Million)
15. Global Liver Panel Tests Market, 2012 – 2020 (USD Million)
16. Global Renal Panel Tests Market, 2012 – 2020 (USD Million)
17. Global Lipid Panel Tests Market, 2012 – 2020 (USD Million)
18. Global Clinical Laboratory Tests Market Revenue Share by Region, 2013 & 2020
19. North America Clinical Laboratory Tests Market, 2012 – 2020 (USD Million)
20. Europe Clinical Laboratory Tests Market, 2012 – 2020 (USD Million)
21. Asia Pacific Clinical Laboratory Tests Market, 2012 – 2020 (USD Million)


【レポート販売概要】

■ タイトル:ケモインフォマティックスの世界市場分析:製品別(全血算定、HGB / HCT検査、基本代謝パネル、BUNクレアチニン検査、電解質検査、HbA1c検査、包括的代謝パネル、肝臓パネル、腎パネル、脂質パネル)、セグメント予測、-2020
■ 英文:Clinical Laboratory Tests Market Analysis By Product (Complete Blood Count, HGB/HCT Tests, Basic Metabolic Panel, BUN Creatinine Tests, Electrolyte Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel) And Segment Forecasts To 2020
■ 発行日:2015年3月1日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707187
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。